| Denise Vera Scots-Knight |
Denise Vera Scots-Knight is the founder of Mereo BioPharma Group Plc, serving as Chief Executive Officer & Director since 2015. Current jobs include Director at Mereo BioPharma 3 Ltd., Director at Mereo BioPharma 2 Ltd. since 2015, Independent Director at Elanco Animal Health, Inc. since 2019, Director at Mereo BioPharma 4 Ltd. since 2017, and President at Mereo BioPharma 5, Inc. since 2019. Former jobs include Chairman-Supervisory Board at Nabriva Therapeutics GmbH from 2007 to 2016, Managing Director at Nomura International Plc from 1999 to 2010, Director at ViaCell, Inc., Independent Director at Idenix Pharmaceuticals LLC from 2011 to 2014, Independent Director at Mereo BioPharma 5, Inc. from 2012 to 2018, Director at Cerimon Pharmaceuticals, Inc., Director at DeveloGen AG from 2011 to 2012, Director at Albireo Ltd., Director at Albireo AB, Independent Director at Albireo Pharma, Inc. from 2008 to 2017, Managing Partner at Phase4 Partners Ltd. from 2011 to 2015, Managing Partner at Phase4 Partners Ltd. from 2010 to 2016, Member at Rothschild Asset Management Ltd. from 1997 to 1999, and Trustee at British Heart Foundation from 2005 to 2012. Education includes undergraduate degrees from the University of California, Berkeley and the University of Birmingham, along with a doctorate from the University of Birmingham. |
